Olivier Jarry

In his current consulting practice, Olivier is supporting the improvement of the offering of Fit4D, a provider of diabetes patient coaching services, to incorporate outcomes measurement, healthcare savings evaluation and more compelling calculations of ROI for the Payers. He and his team are leading several projects to introduce the use of social media in physicians’ relations, “Big Data” techniques in market access as well as algorithms to optimize pipeline value and portfolio value.

At Bristol-Myers Squibb, he upgraded commercial and market access talent for the USD 1 bn Emerging Markets division, to support the launch and growth of innovative medicines (oncology, virology, rheumatology, cardiovascular, diabetes). Olivier and his team re-evaluated the potential of these markets for innovative specialty medicines, leading to the decision of simplifying the organization into a “rest-of-the-world” division and considerably reducing investments.

Grew this USD 1.4 billion business unit at twice the market growth. Became #2 in Europe during my tenure. Reorganized and merged into Bayer Medical Care.

Grow P&L (up to USD 300mn) above market growth organically and through alliances and acquisitions. Design strategy for a business unit (USD 1500 million) and for a division (USD 6000 million).

Re-launched the strategic planning process for the USD 3 billion beverage division that became #1 before Nestlé during my tenure. Led a number of acquisitions (up to USD 1.1 billion) and alliances.

Reorganized North American operations. Acquired several bolt-on businesses.

Sold and led strategic and management consulting projects to 65 clients in durable and consumer goods

Lieutenant in French Air Force